Bictegravir Emtricitabine Tenofovir Alafenamide
4 Topics Found
Drug Index
Bictegravir (INN; BIC, formerly known as GS-9883)[1][2] is a second-generation integrase inhibitor (INSTI) class that was structurally derived from an earlier compound dolutegravir by scientists at Gilead Sciences; in vitro and clinical results were presented by Gilead in the summer of 2016.[3][4] In 2016, bictegravir was in a Phase 3 trial as part of a single tablet regimen in combination with tenofovir alafenamide (TAF) and emt...
NDC Database
Biktarvy Oral Tablet by Gilead Sciences, Inc. ## Package Codes: 61958-2505-1 ## Active Ingredients: Bictegravir Sodium + Emtricitabine + Tenofovir Alafenamide Fumarate
NDC Database
Biktarvy Oral Tablet by Remedyrepack Inc. ## Package Codes: 70518-3080-0, 70518-3080-1 ## Active Ingredients: Bictegravir Sodium + Emtricitabine + Tenofovir Alafenamide Fumarate
NDC Database
Biktarvy Oral Tablet by Gilead Sciences, Inc. ## Markings: GSI;9883 ## Shape: Oval ## Color: Brown ## Package Codes: 61958-2501-1, 61958-2501-2, 61958-2501-3 ## Active Ingredients: Bictegravir Sodium + Emtricitabine + Tenofovir Alafenamide Fumarate